Qualigen Therapeutics Soars 83% After $30 Million Crypto Deal with BitGo

Qualigen Therapeutics stock saw a significant surge of over 83%, following its strategic partnership with BitGo, which involves a $30 million crypto treasury agreement. This move signifies a shift towards blockchain-based finance for the biotech company. The alliance with BitGo promises to enhance digital asset management capabilities and potentially reshape industry standards.